News for 'FDA'

Pfizer seeks approval in India for Covid vaccine

Pfizer seeks approval in India for Covid vaccine

Rediff.com6 Dec 2020

'Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use authorization for its COVID-19 vaccine in India'

PIX: Shocking images on cigarette packs

PIX: Shocking images on cigarette packs

Rediff.com11 Nov 2010

Should Indian cigarette packs also have photos like these to dissuade smokers? Tell us now!

Carcinogens in Johnson baby products?

Carcinogens in Johnson baby products?

Rediff.com16 Mar 2005

The Maharashtra Food and Drug Authority has issued notice to Johnson and Johnson, as six products including baby shampoo and baby oil were found to have carcinogenic substances.

This simple TIP will help you fight coronavirus

This simple TIP will help you fight coronavirus

Rediff.com4 Mar 2020

Meticulous hand washing is your best bet to get rid of the grime that clings to the hand, that might harbour nasty pathogens, including the coronavirus.

Gutkha worth over Rs 7 lakh seized in Maharashtra

Gutkha worth over Rs 7 lakh seized in Maharashtra

Rediff.com1 Feb 2005

The Maharashtra Food and Drug Administration seized gutkha worth over Rs 7 lakh from various parts of the state over the last two days in an effort to enforce the ban on gutkha sales.

COVID-19: Remdesivir will be available from next week

COVID-19: Remdesivir will be available from next week

Rediff.com4 May 2020

The EUA allows for Remdesivir to be distributed in the US and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalised with severe condition.

Manikchand's mineral water under lens

Manikchand's mineral water under lens

Rediff.com23 Jul 2004

The Maharashtra Food and Drug Administration has issued a show cause notice to a Pune-based diversified group for putting 'objectionable' label in its bottled mineral water and seized water bottles worth Rs 245,000 from Aurangabad.

HC quashes ban on Maggi noodles, orders fresh tests

HC quashes ban on Maggi noodles, orders fresh tests

Rediff.com13 Aug 2015

The labs have been asked to submit their report within six weeks.

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

We will prevail: Trump hints at 2024 presidential bid

We will prevail: Trump hints at 2024 presidential bid

Rediff.com1 Mar 2021

Speaking at the Conservative Political Action Committee in Orlando, Florida on Sunday, the 74-year-old leader, who left the White House on January 20, stopped short of announcing to run for the president in 2024, although he gave enough indications that he is moving in that direction.

Dr Reddy's gets warning from US health regulator

Dr Reddy's gets warning from US health regulator

Rediff.com7 Nov 2015

Dr Reddy's gets warning from US health regulator

New York nurse first to get Covid vaccine in US

New York nurse first to get Covid vaccine in US

Rediff.com14 Dec 2020

The news comes as the United States approaches 300,000 deaths from COVID-19.

'When virus is still circulating, older people are more at risk'

'When virus is still circulating, older people are more at risk'

Rediff.com6 Oct 2021

'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'

US court rejects Ranbaxy' plea to block launch by rival cos

US court rejects Ranbaxy' plea to block launch by rival cos

Rediff.com20 Nov 2014

US District Judge Beryl Howell in Minneapolis denied Ranbaxy's request, the court filing showed.

What is ailing India's pharma sector?

What is ailing India's pharma sector?

Rediff.com18 Aug 2016

Low growth visibility and trouble with regulators have resulted in lack of interest from investors

'Why did the government delay the vaccine?'

'Why did the government delay the vaccine?'

Rediff.com14 Apr 2021

'The government had a vaccine from January.' 'The government should have given the vaccine to all population above the age of 45, right from the start.' 'Each state has its own problems, but as far as vaccine coverage in India is concerned, there have been mistakes.'

David vs Goliath: How Wockhardt plans to beat global challenge

David vs Goliath: How Wockhardt plans to beat global challenge

Rediff.com22 Jan 2018

Only 11 antibiotics in clinical trials have received qualified infectious disease product status from the US FDA, of which five are Wockhardt's drugs.

US students who took Covaxin, Sputnik asked to get re-vaccinated

US students who took Covaxin, Sputnik asked to get re-vaccinated

Rediff.com4 Jun 2021

These vaccines have not yet been approved by the World Health Organization

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Sun-Ranbaxy deal signals Indian pharma cos are smart targets

Rediff.com8 Apr 2014

The Ranbaxy experience has made multinational corporations more cautious about Indian acquisitions in general

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Rediff.com6 May 2016

In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.

As drug firms squirm, authorities look abroad for cure

As drug firms squirm, authorities look abroad for cure

Rediff.com23 Sep 2013

DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices

Regulator might inspect Wockhardt units

Regulator might inspect Wockhardt units

Rediff.com12 Jun 2013

Last month, the US Food and Drugs Administration had placed Wockhardt's facilities in Waluj near Aurangabad on import alert, barring supply of various products from these facilities to the US.

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

Raja Krishnamoorthi on why so many Indian Americans are running for office

Raja Krishnamoorthi on why so many Indian Americans are running for office

Rediff.com5 Nov 2020

With an increasing number of people from the Indian-American community playing a significant role in US elections, Congressman Raja Krishnamoorthi said there is a realisation among them that "if you don't have a seat at the table, you're on the menu -- that is why they are voting and running for office in large numbers".

COVID-19 test should not cost more than Rs 4,500: Govt

COVID-19 test should not cost more than Rs 4,500: Govt

Rediff.com22 Mar 2020

This may include Rs 1,500 as a screening test for suspect cases and an additional Rs 3,000 for confirmation test, the guidelines said.

216 cr vaccine doses to be available between Aug-Dec: Centre

216 cr vaccine doses to be available between Aug-Dec: Centre

Rediff.com13 May 2021

As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

More trouble for Ranbaxy; Mohali unit may also have come under USFDA lens

Rediff.com24 Jun 2013

FDA inspectors visited the Mohali plant in the process of giving approval to Ranbaxy's application for Valsartan.

How to DEFEAT the NEXT Pandemic

How to DEFEAT the NEXT Pandemic

Rediff.com3 Nov 2021

Illustrious international thinkers met at the Milken Institute Global Conference 2021 and many discussions addressed the impact of the COVID-19 pandemic on the world at large.

Maharashtra to cancel licences of gutkha cos

Maharashtra to cancel licences of gutkha cos

Rediff.com29 Jan 2005

the Maharashtra Food and Drug Administration on Saturday issued directives to various departments to cancel the licences of gutkha manufacturers, wholesalers and retailers in the state after finding magnesium carbonate in gutkha.

My worry is whether a child is consuming excessive lead: FSSAI CEO

My worry is whether a child is consuming excessive lead: FSSAI CEO

Rediff.com7 Aug 2015

Maggi noodles was recalled in June because some states had found presence of MSG and excessive lead content in the samples.

Why train travel will never be the same again

Why train travel will never be the same again

Rediff.com14 Jul 2020

The first two coaches that rolled out from the Railway Coach Factory in Kapurthala also have fixtures coated with titanium dioxide and the provision for plasma air equipment in AC ducts to sterilise interiors using ionised air. Railway Minister Piyush Goyal also indicated that the new coaches could be the new normal.

Cipla to sell generic Flonase in US

Cipla to sell generic Flonase in US

Rediff.com9 Mar 2006

The US market for the drug is pegged at $1 billion. Cipla has been selling the product in the European market. It had won a similar case in the UK against GSK a couple of years ago.

Booster dose of anti-Covid vax not needed at this stage: Experts

Booster dose of anti-Covid vax not needed at this stage: Experts

Rediff.com18 Sep 2021

As the global debate on booster shots gathers momentum, several scientists in New Delhi said the priority must be to ensure that more people are inoculated with at least their first jab.

USFDA bans more products from Ranbaxy

USFDA bans more products from Ranbaxy

Rediff.com24 Jan 2014

The move follows an FDA inspection of a Ranbaxy facility which identified significant violations of sound manufacturing practices.

A look at Ranbaxy's interesting and eventful history

A look at Ranbaxy's interesting and eventful history

Rediff.com8 Apr 2014

Sun Pharma's acquisition of Ranbaxy has once again revived evaluation of the troubled past of the latter, which had changed hands from the promoters merely five years ago.

Taking anti-malarial drug to protect against virus: Trump

Taking anti-malarial drug to protect against virus: Trump

Rediff.com19 May 2020

Soon after Trump revealed to the world that he has been taking the medicine, the White House doctor said the president is in good health.

Cadbury faces prosecution

Cadbury faces prosecution

Rediff.com7 Oct 2003

Are Indian drugs safe? US doctors worried over quality

Are Indian drugs safe? US doctors worried over quality

Rediff.com18 Mar 2014

Some US doctors are becoming concerned about the quality of generic drugs supplied by Indian manufacturers following a flurry of recalls and import bans by the Food and Drug Administration.

Gutkha sale banned in Maharashtra

Gutkha sale banned in Maharashtra

Rediff.com30 Jan 2005

The move comes after a FDA notice to gutkha manufacturers to mention the contents of their product on the cover.